Literature DB >> 7321156

An autopsied case of an elementary school boy with sudden death four years after Kawasaki disease: on the problem of present method of cardiac mass screening of school children.

T Tanimoto, T Kamiya, H Misawa, H Manabe, S Go, C Yutani.   

Abstract

An 8 year-old boy died suddenly 4 years after the onset of Kawasaki disease. He was examined by a cardiac mass screening for school children one and a half year before the death, and was evaluated as having no sequela of Kawasaki disease. The autopsy showed coronary arterial aneurysms and obstruction with fresh and old myocardial infarction. One of the problems of the present method for cardiac mass screening for school children is that it is performed only with history taking, physical findings and electrocardiograms. This method is completely insufficient to find out coronary involvement as a sequela of Kawasaki disease. All the children with history of Kawasaki disease should be examined by two dimensional echocardiography, which is the most sensitive and specific noninvasive method to detect the coronary involvement in our experience.

Entities:  

Mesh:

Year:  1981        PMID: 7321156     DOI: 10.1253/jcj.45.1438

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  3 in total

1.  Follow-up study of coronary artery lesions due to Kawasaki disease by serial selective coronary arteriography in 200 patients.

Authors:  A Suzuki; T Kamiya; Y Ono; T Kohata; K Kimura; M Takamiya
Journal:  Heart Vessels       Date:  1987       Impact factor: 2.037

2.  Myocardial ischemia in Kawasaki disease: follow-up study by cardiac catheterization and coronary angiography.

Authors:  A Suzuki; T Kamiya; Y Ono; T Kohata; M Okuno
Journal:  Pediatr Cardiol       Date:  1988       Impact factor: 1.655

3.  Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1100 cases.

Authors:  A Suzuki; T Kamiya; N Kuwahara; Y Ono; T Kohata; O Takahashi; K Kimura; M Takamiya
Journal:  Pediatr Cardiol       Date:  1986       Impact factor: 1.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.